Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease

(2022) Alessandro Mantovani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sex Differences in Heart Failure With Preserved Ejection Fraction

(2021) Yohei Sotomi et al.   Journal of the American Heart Association

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

(2021) Tiffany M. Powell-Wiley et al.   CIRCULATION

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

(2021) Giovanni Targher et al.   Lancet Gastroenterology & Hepatology

The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease

(2021) Jake S. Jacob et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Non‐alcoholic fatty liver disease‐related risk of cardiovascular disease and other cardiac complications

(2021) Christopher D. Byrne et al.   DIABETES OBESITY & METABOLISM

Therapeutic potential and recent advances on targeting mitochondrial dynamics in cardiac hypertrophy: A concise review

(2021) Lynn Htet Htet Aung et al.   Molecular Therapy-Nucleic Acids

Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population

(2021) Eun-Ju Cho et al.   Diagnostics

Longitudinal Association of Non‐Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study

(2020) Lisa B. VanWagner et al.   Journal of the American Heart Association

Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea

(2020) Jae-Hyung Roh et al.   BMC Cardiovascular Disorders

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders

(2020) Daniel M. Chopyk et al.   GASTROENTEROLOGY

MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases

(2020) Montserrat Climent et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction

(2020) Alexandria Miller et al.   Scientific Reports

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

(2020) Tracey G Simon et al.   GUT

Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea

(2020) Hwi Jin Im et al.   Clinics and Research in Hepatology and Gastroenterology

Trends in Incidence and Case Fatality Rates of Heart Disease and Its Subtypes in Korea, 2006–2015

(2020) Su Ra Seo et al.   International Journal of Environmental Research and Public Health

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

(2020) Erica Jennison et al.   Clinical and Molecular Hepatology

Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT

(2019) Tomas Vita et al.   RADIOLOGY

Nonalcoholic Fatty Liver Disease and the Heart

(2019) Eric P. Stahl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The degree of hepatic steatosis associates with impaired cardiac and autonomic function

(2019) David Houghton et al.   JOURNAL OF HEPATOLOGY

REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis

(2019) Vlad Ratziu et al.   Contemporary Clinical Trials

Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease

(2019) Milton Packer   AMERICAN JOURNAL OF MEDICINE

Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

(2018) Emelia J. Benjamin et al.   CIRCULATION

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2018) Zobair M. Younossi et al.   HEPATOLOGY

Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis

(2018) Tracey G. Simon et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease

(2018) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases

(2018) Andrew Elagizi et al.   PROGRESS IN CARDIOVASCULAR DISEASES

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

New trends on obesity and NAFLD in Asia

(2017) Jian-Gao Fan et al.   JOURNAL OF HEPATOLOGY

Renin angiotensin system in liver diseases: Friend or foe?

(2017) Ana Cristina Simões e Silva et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Temporal Trends of Hospitalized Patients with Heart Failure in Korea

(2017) Jong-Chan Youn et al.   Korean Circulation Journal

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea

(2016) Sang Cheol Seong et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications

(2016) Sven M. Francque et al.   JOURNAL OF HEPATOLOGY

Epidemiology of Heart Failure in Korea: Present and Future

(2016) Jung Hoon Lee et al.   Korean Circulation Journal

Non-alcoholic fatty liver disease–From the cardiologist perspective

(2016) Oana Sirbu   Anatolian Journal of Cardiology

Heart failure with preserved ejection fraction in women: the Dutch Queen of Hearts program

(2015) H. den Ruijter et al.   Netherlands Heart Journal

Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores

(2014) Yong-ho Lee et al.   PLoS One

Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System

(2014) Sun Ok Song et al.   Diabetes & Metabolism Journal

Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score and the Risk of Incident Diabetes in a Korean population

(2013) Yoosoo Chang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Forecasting the Impact of Heart Failure in the United States

(2013) Paul A. Heidenreich et al.   Circulation-Heart Failure

Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis

(2013) Na Wu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound

(2013) Sofia Carvalhana et al.   LIVER INTERNATIONAL

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

(2012) Lixin Zhu et al.   HEPATOLOGY

Fatty liver index and mortality: The cremona study in the 15th year of follow-up

(2011) Giliola Calori et al.   HEPATOLOGY

Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease

(2010) Takhar Kasumov et al.   METABOLISM-CLINICAL AND EXPERIMENTAL